SAj Blog Archives - Page 58 of 88

The Authors’ Own Words: Awareness of state legislation on naloxone accessibility associated with willingness to prescribe naloxone.

Dec 5, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Awareness of state legislation on naloxone accessibility associated with willingness to prescribe naloxone.

Olihe N. Okoro, PhD, MPH; Karen M. Bastianelli, PharmD; Ya-Feng Wen, PharmD; Elisabeth F. Bilden, MD; Brian K. Konowalchuk, MD; & Mark E. Schneiderhan, PharmD

Substance Abuse Vol. 39, Iss. 1, 2018

“To address the increase in opioid-related deaths, state legislation has been enacted with the intent to increase access of naloxone to high risk individuals. Many clinicians may not be fully aware of naloxone-related state laws that regulate prescribing and distribution of naloxone. The results of this prescriber survey suggest that providers who are more aware of state laws regarding naloxone and confident in their knowledge of dosing, administration, and writing protocols may be more willing to prescribe naloxone. The authors recommend that prescribers be educated on state-specific laws pertaining to naloxone prescribing and use.”

The Authors’ Own Words: The Case of Cannabinoid Hyperemesis Syndrome Associated with Helicobacter Pylori and Pre-Eclampsia in Pregnancy

Dec 4, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

The Case of Cannabinoid Hyperemesis Syndrome Associated with Helicobacter Pylori and Pre-Eclampsia in Pregnancy

Madeline Manning Meurer, MD; Kalyan Chakrala, MD; Dinesh Gowda, MD; Charles Burns, MD; Randall Kelly, MD; & Natalia Schlabritz-Loutsevitch, MD, PhD

Substance Abuse Vol. 39, Iss. 1, 2018

“There is the urgent need to study the effects of cannabis use in pregnant women, particularly considering the fact that no US states provide guidelines on the possible harmful effects of marijuana use during pregnancy. The use of substance abuse during pregnancy could be masked by pregnancy-specific complications. In particular, cannabinoid hyperemesis syndrome (CHS), described in chronic cannabis users, represents a challenging diagnosis in pregnancy. The described case adds to the published few cases of CHS in pregnant women. This case raises awareness of the health care providers to the timely diagnosis of complications of marijuana use in pregnancy and provides possible link of marijuana use to pre-eclampsia and H. Pylori colonization.”

The Authors’ Own Words: Reducing Opioid Misuse Among Adolescents through Physician Education

Dec 4, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Reducing Opioid Misuse Among Adolescents through Physician Education

Nonie S. Arora, BS; Kayla M. Marcotte, MS; & John A. Hopper, MD

Substance Abuse Vol. 39, Iss. 1, 2018

“Our Letter to the Editor comments on the need for increased awareness and training regarding opioid misuse, pain management, and addiction treatment among physicians who treat adolescents. Given that substance misuse often begins in adolescence, it is a critical time for prevention and intervention for opioid misuse disorders. Through the implementation of evidence-based educational strategies and physician mentorship programs, we can strive for safe and effective opioid prescription to adolescents as well as appropriate management of pain and addiction.”

The Authors’ Own Words: Drug helplines and adult users of marijuana: an assessment in Washington, Colorado, Oregon, and Alaska

Dec 3, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Drug helplines and adult users of marijuana: an assessment in Washington, Colorado, Oregon, and Alaska

Beatriz H. Carlini, PhD, MPH; & Sharon B. Garrett, MPH, MA

Substance Abuse Vol. 39, Iss. 1, 2018

“Our findings suggests that drug helplines are not fully prepared to provide accurate information to people interested in cutting back their use of marijuana. This has public health implications as our study was conducted in states that recently legalized marijuana and drug helplines are often the first resource accessed by people interested in changing their substance use. Our work identifies the need of improving helpline staff skills and knowledge, and provides a map of some weaknesses and strengths in this area that can be used in quality improvement and training initiatives.”

Substance Abuse journal Volume 40 | Issue 3

Dec 2, 2019 by AMERSA

What a fantastic issue! It was so informative and dare we say – fun! – to catch up with Volume 40, Issue 3. If you haven’t read it yet, you always can here.

If you have read this issue or you have been following along with this issue’s Authors’ Own Words, you may have noticed that many of the pieces in this issue having something in common. No, you aren’t just reading into it or think we are being redundant – Volume 40, Issue 3 had a special section! This issue had a Special Section on Substance Use Disorder Quality Metrics. We also especially enjoy special issues or sections, we hope you do too!

The most viewed piece of work in this issue was:
IT’S A TIE!

Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014–2015

Constance Weisner, DrPH, MSW; Cynthia I. Campbell, PhD, MPH; Andrea Altschuler, PhD; Bobbi Jo H. Yarborough, PsyD; Gwen T. Lapham, PhD, MPH, MSW; Ingrid A. Binswanger, MD, MPH, MS; Rulin C. Hechter , MD, PhD; Brian K. Ahmedani, PhD, LMSW; Irina V. Haller, PhD, MS; Stacy A. Sterling, DrPH, MSW; Dennis McCarty, PhD; Derek D. Satre, PhD; & Andrea H. Kline-Simon, MS

with 542 views (and counting!)

Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) treatment initiation and engagement among patients with opioid use disorder across 7 health systems

Cynthia I. Campbell, PhD, MPH; Constance Weisner, DrPH, MSW; Ingrid A. Binswanger, MD, MPH, MS; Gwen T. Lapham, PhD, MPH, MSW; Brian K. Ahmedani PhD, LMSW; Bobbi Jo H. Yarborough, PsyD; Irina V. Haller, PhD, MS; Andrea Altschuler, PhD; Rulin C. Hechter, MD, PhD; Amy M. Loree, PhD; & Andrea H. Kline-Simon, MS

ALSO 542 views (and counting!)

These two papers don’t only have view count in common, they also share some authors and themes! Check them out now!